PCM
IRWD icon

Penserra Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Penserra Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,725
Closed -$48K – 1449
2021
Q3 		$48K Buy
3,725
+40
+1% +$517 ﹤0.01% 1061
2021
Q2 		$47K Buy
3,685
+35
+1% +$401 ﹤0.01% 1017
2021
Q1 		$40K Sell
3,650
-80
-2% -$845 ﹤0.01% 848
2020
Q4 		$42K Buy
3,730
+2,364
+173% +$25.9K ﹤0.01% 714
2020
Q3 		$12K Buy
+1,366
New +$13.6K ﹤0.01% 801

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Penserra Capital Management's IRWD Position: Q4 2021 in Review

Penserra Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2021, closing a stake of 3,725 shares — an estimated $48K sold.

Penserra Capital Management first reported a position in IRWD in Q3 2020 and held it in 5 quarters. The position peaked at $48K in Q3 2021. 212 funds tracked by Wall St. Rank hold IRWD as of Q4 2021.

  • Penserra Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 3,725 Ironwood Pharmaceuticals shares in Q4 2021, an estimated $48K.
  • Penserra Capital Management first reported a position in Ironwood Pharmaceuticals in Q3 2020 and held it in 5 quarters.
  • Penserra Capital Management's Ironwood Pharmaceuticals position peaked at $48K in Q3 2021.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.